RTI DATA

Osimert 80 mg tablets contain the active ingredient Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used in the treatment of specific types of non-small cell lung cancer (NSCLC). Osimertinib targets both EGFR-sensitizing mutations and the T790M...

Avalet 20 mg, containing the active ingredient Avatrombopag, is a thrombopoietin receptor agonist used primarily to treat thrombocytopenia (low blood platelet count) in individuals with chronic liver disease undergoing medical procedures or in patients with chronic immune thrombocytopenia (ITP). Ava...

Osimertinib is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that has revolutionized the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Marketed under the brand name Tagrisso, osimertinib has demonstrated remarkable suc...

Osimertinib (brand name Tagrisso) is a medication used to treat certain types of non-small cell lung cancer. While it doesn't have extensive food interactions, being mindful of certain dietary considerations can help optimize its effectiveness and minimize potential side effects. Grapefruit and Grap...

Tofacitinib is an oral medication that belongs to the class of Janus kinase (JAK) inhibitors. It has been widely used in the treatment of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ulcerative colitis (UC). Approved by the U.S. Food and Drug Administration (...